Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Curcumin for Pain of CMC Arthritis
NCT06359665Phase 1Enrolling by invitation
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of curcumin in Osteoarthritis of the first carpometacarpal joint (2 arms). Primary endpoint: Visual Analog Pain Score at Week 12. Started Feb 2025; status: enrolling by invitation.
02
Drugs
curcumin
03
Conditions
Osteoarthritis of the first carpometacarpal joint
Beyond the preview
Go deeper on NCT06359665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06359665.